Scientists at University of Michigan, Department of Radiation Oncology target head and neck cancer therapy

Scientists discuss in "Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo" new findings in head and neck cancer. Researchers in the United States conducted a study "To optimally integrate epidermal growth factor receptor (EGFR) inhibitors into the clinical treatment of head and neck cancer, two important questions must be answered: (a) does EGFR inhibition add to the effects of radiochemotherapy, and (b) if so, which method of inhibiting EGFR is superior (an EGFR antibody versus a small molecule tyrosine kinase inhibitor)' We designed an in vivo study to address these questions. Nude mice with...

Want to see the full article?

• Purchase this article for only $3.00